279 related articles for article (PubMed ID: 25537270)
21. Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation.
Markowicz-Piasecka M; Huttunen KM; Sikora J
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1309-1322. PubMed ID: 30251898
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer's disease.
Arce MP; Rodríguez-Franco MI; González-Muñoz GC; Pérez C; López B; Villarroya M; López MG; García AG; Conde S
J Med Chem; 2009 Nov; 52(22):7249-57. PubMed ID: 19856923
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of donepezil-based multifunctional agents for the treatment of Alzheimer's disease.
Yerdelen KO; Koca M; Anil B; Sevindik H; Kasap Z; Halici Z; Turkaydin K; Gunesacar G
Bioorg Med Chem Lett; 2015 Dec; 25(23):5576-82. PubMed ID: 26514744
[TBL] [Abstract][Full Text] [Related]
24. Quinolone-benzylpiperidine derivatives as novel acetylcholinesterase inhibitor and antioxidant hybrids for Alzheimer disease.
Pudlo M; Luzet V; Ismaïli L; Tomassoli I; Iutzeler A; Refouvelet B
Bioorg Med Chem; 2014 Apr; 22(8):2496-507. PubMed ID: 24657052
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, biological activity and molecular modeling studies on 1H-benzimidazole derivatives as acetylcholinesterase inhibitors.
Alpan AS; Parlar S; Carlino L; Tarikogullari AH; Alptüzün V; Güneş HS
Bioorg Med Chem; 2013 Sep; 21(17):4928-37. PubMed ID: 23891231
[TBL] [Abstract][Full Text] [Related]
26. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and biological activity of multifunctional α,β-unsaturated carbonyl scaffolds for Alzheimer's disease.
Bag S; Ghosh S; Tulsan R; Sood A; Zhou W; Schifone C; Foster M; LeVine H; Török B; Török M
Bioorg Med Chem Lett; 2013 May; 23(9):2614-8. PubMed ID: 23540646
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, Biological Evaluation, and Molecular Docking of 8-imino-2-oxo-2H,8H-pyrano[2,3-f]chromene Analogs: New Dual AChE Inhibitors as Potential Drugs for the Treatment of Alzheimer's Disease.
Shaik JB; Palaka BK; Penumala M; Eadlapalli S; Darla Mark M; Ampasala DR; Vadde R; Amooru Gangaiah D
Chem Biol Drug Des; 2016 Jul; 88(1):43-53. PubMed ID: 26833890
[TBL] [Abstract][Full Text] [Related]
29. Discovery of novel 2,6-disubstituted pyridazinone derivatives as acetylcholinesterase inhibitors.
Xing W; Fu Y; Shi Z; Lu D; Zhang H; Hu Y
Eur J Med Chem; 2013 May; 63():95-103. PubMed ID: 23466605
[TBL] [Abstract][Full Text] [Related]
30. Investigating 1,2,3,4,5,6-hexahydroazepino[4,3-b]indole as scaffold of butyrylcholinesterase-selective inhibitors with additional neuroprotective activities for Alzheimer's disease.
Purgatorio R; de Candia M; Catto M; Carrieri A; Pisani L; De Palma A; Toma M; Ivanova OA; Voskressensky LG; Altomare CD
Eur J Med Chem; 2019 Sep; 177():414-424. PubMed ID: 31158754
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents.
Luo W; Su YB; Hong C; Tian RG; Su LP; Wang YQ; Li Y; Yue JJ; Wang CJ
Bioorg Med Chem; 2013 Dec; 21(23):7275-82. PubMed ID: 24148835
[TBL] [Abstract][Full Text] [Related]
32. Novel huprine derivatives with inhibitory activity toward β-amyloid aggregation and formation as disease-modifying anti-Alzheimer drug candidates.
Viayna E; Gómez T; Galdeano C; Ramírez L; Ratia M; Badia A; Clos MV; Verdaguer E; Junyent F; Camins A; Pallàs M; Bartolini M; Mancini F; Andrisano V; Arce MP; Rodríguez-Franco MI; Bidon-Chanal A; Luque FJ; Camps P; Muñoz-Torrero D
ChemMedChem; 2010 Nov; 5(11):1855-70. PubMed ID: 20859987
[TBL] [Abstract][Full Text] [Related]
33. Multifunctional hybrid sulfonamides as novel therapeutic agents for Alzheimer's disease.
Swetha R; Kumar D; Gupta SK; Ganeshpurkar A; Singh R; Gutti G; Kumar D; Jana S; Krishnamurthy S; Singh SK
Future Med Chem; 2019 Dec; 11(24):3161-3178. PubMed ID: 31838895
[No Abstract] [Full Text] [Related]
34. Biological evaluation of synthetic α,β-unsaturated carbonyl based cyclohexanone derivatives as neuroprotective novel inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation.
Zha GF; Zhang CP; Qin HL; Jantan I; Sher M; Amjad MW; Hussain MA; Hussain Z; Bukhari SN
Bioorg Med Chem; 2016 May; 24(10):2352-9. PubMed ID: 27083471
[TBL] [Abstract][Full Text] [Related]
35. Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors.
Darreh-Shori T; Hosseini SM; Nordberg A
J Alzheimers Dis; 2014; 39(2):423-40. PubMed ID: 24217282
[TBL] [Abstract][Full Text] [Related]
36. Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Brunhofer G; Fallarero A; Karlsson D; Batista-Gonzalez A; Shinde P; Gopi Mohan C; Vuorela P
Bioorg Med Chem; 2012 Nov; 20(22):6669-79. PubMed ID: 23062825
[TBL] [Abstract][Full Text] [Related]
37. Active site directed docking studies: synthesis and pharmacological evaluation of cis-2,6-dimethyl piperidine sulfonamides as inhibitors of acetylcholinesterase.
Girisha HR; Narendra Sharath Chandra JN; Boppana S; Malviya M; Sadashiva CT; Rangappa KS
Eur J Med Chem; 2009 Oct; 44(10):4057-62. PubMed ID: 19493592
[TBL] [Abstract][Full Text] [Related]
38. Tetrahydroacridine derivatives with dichloronicotinic acid moiety as attractive, multipotent agents for Alzheimer's disease treatment.
Czarnecka K; Chufarova N; Halczuk K; Maciejewska K; Girek M; Skibiński R; Jończyk J; Bajda M; Kabziński J; Majsterek I; Szymański P
Eur J Med Chem; 2018 Feb; 145():760-769. PubMed ID: 29353726
[TBL] [Abstract][Full Text] [Related]
39. N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents.
Košak U; Knez D; Coquelle N; Brus B; Pišlar A; Nachon F; Brazzolotto X; Kos J; Colletier JP; Gobec S
Bioorg Med Chem; 2017 Jan; 25(2):633-645. PubMed ID: 27908752
[TBL] [Abstract][Full Text] [Related]
40. Exploiting the Chalcone Scaffold to Develop Multifunctional Agents for Alzheimer's Disease.
Rampa A; Bartolini M; Pruccoli L; Naldi M; Iriepa I; Moraleda I; Belluti F; Gobbi S; Tarozzi A; Bisi A
Molecules; 2018 Jul; 23(8):. PubMed ID: 30061534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
